News

Fintel on MSN7h
Wells Fargo Initiates Coverage of Sarepta Therapeutics (SRPT) with Overweight Recommendation
Fintel reports that on April 11, 2025, Wells Fargo initiated coverage of Sarepta Therapeutics (NasdaqGS:SRPT) with a ...
American Association of Individual Investors11h
Which Is a Better Investment, Alvotech or Sarepta Therapeutics, Inc. Stock?
Learn more about whether Alvotech or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Sarepta initiated with a bullish view at Wells Fargo on Elevidys
Sarepta Therapeutics (NASDAQ:SRPT) stock draws an Overweight rating at Wells Fargo, based on commercial prospects for ...
Sarepta initiated with an Overweight at Wells Fargo
Wells Fargo initiated coverage of Sarepta (SRPT) with an Overweight rating and $115 price target Despite the recent Gr5 AE case, the firm ...